Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC), 58669-58670 [E7-20387]

Download as PDF 58669 Federal Register / Vol. 72, No. 199 / Tuesday, October 16, 2007 / Notices DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration (HRSA) publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, call the HRSA Reports Clearance Office on (301) 443–1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Proposed Project The HRSA Uniform Progress Report (UPR) is used for the preparation and submission of continuation applications for Title VII and VIII health professions and nursing education and training programs. The UPR measures grantee success in meeting (1) the objectives of the grant project, and (2) the crosscutting outcomes developed for the Bureau of Health Professions’ education and training programs. Part I of the progress report is designed to collect information to determine whether sufficient progress has been made on the approved project objectives, as grantees must demonstrate satisfactory progress to warrant continuation of funding. Part II collects information on activities specific to a given program. Part III, the Comprehensive Performance Management System (CPMS), collects data on overall project performance related to the Bureau’s strategic goals, objectives, outcomes, and indicators. Progress will be measured based on the Number of respondents Report Responses per respondent objectives of the grant project, and outcome measures and indicators developed by the Bureau to meet requirements of the Government Performance and Results Act (GPRA). The Bureau has simplified several tables in UPR II and added the ability for grantees to provide better race and ethnicity data. In addition, to respond to the requirements of GPRA, the Bureau has revised its cross-cutting goals, expected outcomes, and indicators in UPR III CPMS that provide the framework for collection of outcome data for its Title VII and VIII programs. An outcome-based performance system is critical for measuring whether program support is meeting national health workforce objectives. At the core of the performance measurement system are found cross-cutting goals with respect to workforce quality, supply, diversity, and distribution of the health professions workforce. The estimated annual burden is as follows: Total responses Hours per response Total burden hours Uniform Progress Report ..................................................... 1,500 1 1,500 7 10,500 Total .............................................................................. 1,500 ........................ 1,500 ........................ 10,500 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to the desk officer for HRSA, either by e-mail to OIRA_submission@omb.eop.gov or by fax to 202–395–6974. Please direct all correspondence to the ‘‘attention of the desk officer for HRSA.’’ Dated: October 9, 2007. Alexandra Huttinger, Acting Director, Division of Policy Review and Coordination. [FR Doc. E7–20383 Filed 10–15–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration mmaher on PROD1PC70 with NOTICES Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC) Health Resources and Services Administration (HRSA), HHS. AGENCY: Notice of ACHDGDNC Meeting to be held by Conference Call. ACTION: VerDate Aug<31>2005 04:12 Oct 16, 2007 Jkt 214001 SUMMARY: The ACHDGDNC will be conducting a two hour conference call to hear a presentation from the ACHDGDNC’s Evidence Review Workgroup and discuss the Committee’s Report on long-term followup. The conference call will be held on November 14, 2007, at 2 p.m. EST. Participants must dial: 1–877–922–9969 and enter the corresponding pass code 627445. For security reasons, the pass code 627445 is required to join the call. Participants should call no later than 1:50 p.m. EST in order for the logistics to be set up. Participants are asked to register for the conference by contacting Carrie Diener at (301) 443–1080 or email cdiener@hrsa.gov. The registration deadline is November 12, 2007. The Department will try to accommodate those wishing to participate in the call. Any member of the public can submit written materials that will be distributed to Committee members prior to the conference call. Parties wishing to submit written comments should ensure that the comments are postmarked or emailed no later than November 12, 2007, for consideration. Comments should be submitted to Michele A. Lloyd-Puryear, Executive Secretary, ACHDGDNC, Maternal and Child Health DATES: PO 00000 Frm 00039 Fmt 4703 Sfmt 4703 Bureau, HRSA, Parklawn Building, Room 18A–19, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443–1080; fax (301) 443–8604; or e-mail: mpuryear@hrsa.gov. Members of the public can present oral comments during the conference call during the public comment period. If a member of the public wishes to speak, the Department should be notified at the time the participant registers. Other members of the public will be allocated time if time permits. FOR FURTHER INFORMATION CONTACT: Michele A. Lloyd-Puryear, Executive Secretary, ACHDGDNC, Maternal and Child Health Bureau, HRSA, Parklawn Building, Room 18A–19, 5600 Fishers Lane, Rockville, Maryland 20857; telephone (301) 443–1080; fax (301) 443–8604; or e-mail: mpuryear@hrsa.gov. The ACHDGDNC was chartered under Section 1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b–10, in February 2003 to advise the Secretary of the U.S. Department of Health and Human Services. The ACHDGDNC is directed to review and report regularly on newborn and childhood screening practices for heritable disorders, to SUPPLEMENTARY INFORMATION: E:\FR\FM\16OCN1.SGM 16OCN1 58670 Federal Register / Vol. 72, No. 199 / Tuesday, October 16, 2007 / Notices recommend improvements in the national newborn and childhood heritable screening programs, and to engage in the following activities: (1) Provide advice and recommendations to the Secretary concerning grants and projects awarded or funded under its designated authorizing PHS Act; (2) Provide technical information to the Secretary for the development of policies and priorities for the administration of grants under the designated PHS act; and (3) Provide such recommendations, advice or information as may be necessary to enhance, expand or improve the ability of the Secretary to reduce the mortality or morbidity in newborns and children from heritable disorders. The purpose of this call is to hear discussion from the ACHDGDNC members on the proposed review template from the ACHDGDNC’s Evidence Workgroup and, if the ACHDGDNC chooses, to approve that template. In addition, the ACHDGDNC may choose to develop recommendations from the ACHDGDNC to the Secretary concerning the ACHDGDNC’s evaluation and decisionmaking process and newborn screening long-term followup. Dated: October 9, 2007. Alexandra Huttinger, Acting Director, Division of Policy Review and Coordination. [FR Doc. E7–20387 Filed 10–15–07; 8:45 am] BILLING CODE 4165–15–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Cancer Institute; Amended Notice of Meeting mmaher on PROD1PC70 with NOTICES Notice is hereby given of a change in the meeting of the President’s Cancer Panel, October 22, 2007, 8 a.m. to October 22, 2007, 6:30 p.m., Hyatt Regency La Jolla, 3777 La Jolla Village Drive, San Diego, CA 92122 which was published in the Federal Register on September 26, 2007, 72 FR 54667. This meeting is being amended to reschedule the closed session to Tuesday, October 30, 2007, 2 p.m.–4 p.m., as a telephone conference. The meeting is closed to the public. DEPARTMENT OF HEALTH AND HUMAN SERVICES DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institutes of Health National Cancer Institute; Notice of Meeting National Center for Research Resources; Notice of Closed Meetings Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Cancer Institute Board of Scientific Advisors. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Cancer Institute Board of Scientific Advisors. Date: November 15–16, 2007. Time: November 15, 2007, 8 a.m. to 6 p.m. Agenda: Director’s Report: Ongoing and New Business; Reports of Program Review Group(s); and Budget Presentation; Reports of Special Initiatives; RFA and RFP Concept Reviews; and Scientific Presentations. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Time: November 16, 2007, 8:30 a.m. to 1 p.m. Agenda: Reports of Special Initiatives; RFA and RFP Concept Reviews; and Scientific Presentations. Place: National Institutes of Health, Building 31, 31 Center Drive, 6th Floor, Conference Room 10, Bethesda, MD 20892. Contact Person: Paulette S. Gray, PhD, Executive Secretary, Director, Division of Extramural Activities, National Cancer Institute, National Institutes of Health, 6116 Executive Boulevard, 8th Floor, RM. 8001, Bethesda, MD 20892, 301–496–5147, grayp@mail.nih.gov. Information is also available on the Institute’s/Center’s home page: deainfo.nci.nih.gov/advisory/bsa.htm, where an agenda and any additional information for the meeting will be posted when available. (Catalogue of Federal Domestic Assistance Program Nos. 93.392, Cancer Construction; 93.393, Cancer Cause and Prevention Research; 93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer Control, National Institutes of Health, HHS) Dated: October 5, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5093 Filed 10–15–07; 8:45 am] Dated: October 10, 2007. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. 07–5095 Filed 10–15–07; 8:45 am] BILLING CODE 4140–01–M BILLING CODE 4140–01–M VerDate Aug<31>2005 04:12 Oct 16, 2007 Jkt 214001 PO 00000 Frm 00040 Fmt 4703 Sfmt 4703 Name of Committee: National Center for Research Resources Special Emphasis Panel; Conference Grant SEP. Date: October 31, 2007. Time: 1 p.m. to 3 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy Boulevard, Room—1087, Bethesda, MD 20892 (Telephone Conference Call). Contact Person: Steven Birken, PhD, Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Democracy Blvd., 10th Fl., Bethesda, MD 20892, (301) 435–1078, birkens@mail.nih.gov. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. Name of Committee: National Center for Research Resources Special Emphasis Panel; C.O.B.R.E.—SEP. Date: November 1, 2007. Time: 8 a.m. to 5 p.m. Agenda: To review and evaluate grant applications. Place: Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. Contact Person: Linda C. Duffy, PhD, Scientific Review Administrator, Office of Review, National Center for Research Resources, National Institutes of Health, 6701 Dem. Blvd., 1 Dem, Plaza, Rm. 1082, MSC 4874, Bethesda, MD 20892–4874, 301–435– 0810, duffyl@mail.nih.gov. Name of Committee: National Center for Research Resources Special Emphasis Panel; Comparative Medicine SEP. Date: November 7, 2007. Time: 2:30 p.m. to 5:30 p.m. Agenda: To review and evaluate grant applications. Place: National Institutes of Health, One Democracy Plaza, 6701 Democracy E:\FR\FM\16OCN1.SGM 16OCN1

Agencies

[Federal Register Volume 72, Number 199 (Tuesday, October 16, 2007)]
[Notices]
[Pages 58669-58670]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-20387]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Health Resources and Services Administration


Advisory Committee on Heritable Disorders and Genetic Diseases in 
Newborns and Children (ACHDGDNC)

AGENCY: Health Resources and Services Administration (HRSA), HHS.

ACTION: Notice of ACHDGDNC Meeting to be held by Conference Call.

-----------------------------------------------------------------------

SUMMARY: The ACHDGDNC will be conducting a two hour conference call to 
hear a presentation from the ACHDGDNC's Evidence Review Workgroup and 
discuss the Committee's Report on long-term followup.

DATES:  The conference call will be held on November 14, 2007, at 2 
p.m. EST. Participants must dial: 1-877-922-9969 and enter the 
corresponding pass code 627445. For security reasons, the pass code 
627445 is required to join the call. Participants should call no later 
than 1:50 p.m. EST in order for the logistics to be set up. 
Participants are asked to register for the conference by contacting 
Carrie Diener at (301) 443-1080 or e-mail cdiener@hrsa.gov. The 
registration deadline is November 12, 2007. The Department will try to 
accommodate those wishing to participate in the call. Any member of the 
public can submit written materials that will be distributed to 
Committee members prior to the conference call. Parties wishing to 
submit written comments should ensure that the comments are postmarked 
or emailed no later than November 12, 2007, for consideration. Comments 
should be submitted to Michele A. Lloyd-Puryear, Executive Secretary, 
ACHDGDNC, Maternal and Child Health Bureau, HRSA, Parklawn Building, 
Room 18A-19, 5600 Fishers Lane, Rockville, Maryland 20857; telephone 
(301) 443-1080; fax (301) 443-8604; or e-mail: mpuryear@hrsa.gov.
    Members of the public can present oral comments during the 
conference call during the public comment period. If a member of the 
public wishes to speak, the Department should be notified at the time 
the participant registers. Other members of the public will be 
allocated time if time permits.

FOR FURTHER INFORMATION CONTACT: Michele A. Lloyd-Puryear, Executive 
Secretary, ACHDGDNC, Maternal and Child Health Bureau, HRSA, Parklawn 
Building, Room 18A-19, 5600 Fishers Lane, Rockville, Maryland 20857; 
telephone (301) 443-1080; fax (301) 443-8604; or e-mail: 
mpuryear@hrsa.gov.

SUPPLEMENTARY INFORMATION: The ACHDGDNC was chartered under Section 
1111 of the Public Health Service (PHS) Act, 42 U.S.C. 300b-10, in 
February 2003 to advise the Secretary of the U.S. Department of Health 
and Human Services. The ACHDGDNC is directed to review and report 
regularly on newborn and childhood screening practices for heritable 
disorders, to

[[Page 58670]]

recommend improvements in the national newborn and childhood heritable 
screening programs, and to engage in the following activities:
    (1) Provide advice and recommendations to the Secretary concerning 
grants and projects awarded or funded under its designated authorizing 
PHS Act;
    (2) Provide technical information to the Secretary for the 
development of policies and priorities for the administration of grants 
under the designated PHS act; and
    (3) Provide such recommendations, advice or information as may be 
necessary to enhance, expand or improve the ability of the Secretary to 
reduce the mortality or morbidity in newborns and children from 
heritable disorders.
    The purpose of this call is to hear discussion from the ACHDGDNC 
members on the proposed review template from the ACHDGDNC's Evidence 
Workgroup and, if the ACHDGDNC chooses, to approve that template. In 
addition, the ACHDGDNC may choose to develop recommendations from the 
ACHDGDNC to the Secretary concerning the ACHDGDNC's evaluation and 
decisionmaking process and newborn screening long-term followup.

    Dated: October 9, 2007.
Alexandra Huttinger,
Acting Director, Division of Policy Review and Coordination.
 [FR Doc. E7-20387 Filed 10-15-07; 8:45 am]
BILLING CODE 4165-15-P